By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Immunomedics, Inc. 

300 American Road

Morris Plains  New Jersey  07950-2450  U.S.A.
Phone: 201-605-8200 Fax: 973-605-8282



Company News
Published Results From Clinical Trials Demonstrate Therapeutic Potential For Immunomedics (IMMU)’ Sacituzumab Govitecan (IMMU-132) In The Treatment Of Metastatic Solid Cancers 7/10/2017 9:04:17 AM
Immunomedics (IMMU) Announces Third Quarter Fiscal 2017 Results And Clinical Program Developments 5/11/2017 1:18:22 PM
Immunomedics (IMMU) Announces Conference Call And Webcast For Third Quarter Fiscal 2017 Results 5/10/2017 9:04:49 AM
Immunomedics (IMMU) Rise Too Much As Seattle Genetics (SGEN) Deal Terminated? 5/8/2017 7:06:05 AM
Immunomedics (IMMU) Delivers Business Updates, Announces Private Placement Offering And Outlines Strategic Steps To Drive Stockholder Value 5/5/2017 8:31:47 AM
Stock Soars as Immunomedics (IMMU) CEO, COO Exit and Seattle Genetics (SGEN) Dumps $2 Billion Deal 5/5/2017 7:05:39 AM
Immunomedics (IMMU) Catches a Break With Positive Mid-Stage Lung Cancer Data 4/5/2017 11:54:30 AM
Immunomedics (IMMU) Announces Publication Of Results In Journal Of Clinical Oncology, Demonstrating Treatment With Sacituzumab Govitecan (IMMU-132) Produces Early And Durable Responses In Patients With Metastatic Triple-Negative Breast Cancer 3/15/2017 6:36:19 AM
A Win for venBio as Judge Hits Pause on Immunomedics (IMMU)'s $2 Billion Deal With Seattle Genetics (SGEN) 3/10/2017 5:59:38 AM
Immunomedics (IMMU) Board Institutes Measures As Stockholder Fiduciaries To Preserve Their Best Business Judgment To Protect The Rights Of All Stockholders 3/3/2017 11:03:47 AM